Tue, October 27, 2009
Mon, October 26, 2009
Sun, October 25, 2009
Fri, October 23, 2009
Thu, October 22, 2009
Wed, October 21, 2009
Tue, October 20, 2009
Mon, October 19, 2009
Fri, October 16, 2009
Thu, October 15, 2009
Wed, October 14, 2009
Tue, October 13, 2009
Mon, October 12, 2009
Fri, October 9, 2009
Thu, October 8, 2009
Wed, October 7, 2009
Tue, October 6, 2009
Mon, October 5, 2009
Sun, October 4, 2009
Fri, October 2, 2009
Thu, October 1, 2009
Wed, September 30, 2009
Tue, September 29, 2009
Mon, September 28, 2009
Fri, September 25, 2009
Thu, September 24, 2009
Wed, September 23, 2009
Tue, September 22, 2009
Mon, September 21, 2009
Fri, September 18, 2009
Thu, September 17, 2009
Wed, September 16, 2009
Tue, September 15, 2009
Mon, September 14, 2009
Fri, September 11, 2009
Thu, September 10, 2009
Wed, September 9, 2009
Tue, September 8, 2009

Sanguine Corporation: Sanguine Subsidiary to Change Name From Sanguine Life Sciences to SGN Life Sciences


//health-fitness.news-articles.net/content/2009/ .. sanguine-life-sciences-to-sgn-life-sciences.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


PASADENA, CA--(Marketwire - October 6, 2009) - Sanguine Corp (OTCBB: [ SGUI ]) announced today that it will change the name of its wholly-owned subsidiary, Sanguine Life Sciences, to SGN Life Sciences. The Company explained that the name change is necessary to better reflect the subsidiary's intended business model. Company spokesperson, Mr. Frank Marra, explained, "When we decided to set up the Sanguine Life Sciences subsidiary we did so primarily for the purpose of seeking partnering relationships or merger candidates for PHER-O2. However, it has become clear that the scope of the subsidiary can represent much more opportunity to the Company. We intend to use the SGN Subsidiary to take advantage of market opportunities that have presented themselves to us; which includes, but is not limited to, PHER-O2 potential collaborations. Quite frankly, we are seeking, and have been in conversations with, potential partnership, merger and/or acquisition candidates that can move the Company towards revenue generation."

Mr. Marra added, "In recent months we have been actively working to find the proper relationship to assist us in taking PHER-O2 to the next level. We believe that there are a number of very exciting opportunities for PHER-O2 in the marketplace and we are in the process of determining the best possible partner, or partners, for us."

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence on third-party suppliers, and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.


Publication Contributing Sources

Similar Health and Fitness Publications